Montelukast Sodium

Montelukast Sodium is an active pharmaceutical ingredient (API) widely recognized for its efficacy in the treatment and management of asthma and allergic rhinitis. Montelukast Sodium acts as a selective and competitive leukotriene receptor antagonist, inhibiting the cysteinyl leukotriene (CysLT1) receptor responsible for airway inflammation, bronchoconstriction, and mucus secretion. Montelukast Sodium blocks leukotriene activity and improves breathing, reduces symptoms of asthma, and prevents exercise-induced bronchospasm.

Chemox Pharma is a trusted manufacturer of Montelukast Sodium API in IP/EP/USP standards. Chemox Pharma deliver high-quality APIs with stringent compliance to international regulatory requirements. Our API products are relied upon by leading pharmaceutical companies, showcasing our strong global presence. All our facilities operate under regulatory authorities such as DCGI, WHO-GMP, and FDA, ensuring consistency, safety, and efficacy.